pVAX14DNA-mediated add-on immunotherapy combined with arsenic trioxide and all-trans retinoic acid targeted therapy effectively increases the survival of acute promyelocytic leukemia mice

Detalles Bibliográficos
Autores principales: Patel, S, Guerenne, L, Gorombei, P, Omidvar, N, Schlageter, M-H, Alex, A A, Ganesan, S, West, R, Adès, L, Mathews, V, Krief, P, Pla, M, Fenaux, P, Chomienne, C, Padua, R A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4735069/
https://www.ncbi.nlm.nih.gov/pubmed/26657197
http://dx.doi.org/10.1038/bcj.2015.102

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4735069/
https://www.ncbi.nlm.nih.gov/pubmed/26657197
http://dx.doi.org/10.1038/bcj.2015.102

Ejemplares similares